Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Taizhou Hengfeng Pharmaceutical & Chemical is a China-based pharmaceutical and chemical manufacturer focused on small-molecule pharmaceutical intermediates, active ingredients, and related chemical products. The company appears to operate primarily as a supplier/manufacturer rather than a drug developer, with commercial products including compounds such as isotretinoin, tretinoin, acitretin, cytidine, adenine derivatives, aztreonam intermediates, topiramate, triclabendazole, pentamidine isethionate, and epalrestat. Publicly available company-profile sources describe it as a pharmaceutical and chemical producer located in Linhai, Zhejiang, and Chinese business-registry data list it as an active enterprise engaged in manufacturing and selling pharmaceutical intermediates. Based on the available evidence, Hengfeng is best characterized as a commercial-stage small-molecule pharma chemicals/API-intermediates company rather than an innovative clinical biotech with a disclosed therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hengfeng Pharmaceutical.